Healixa Inc.

OTCPK:EMOR Stock Report

Market Cap: US$35.2m

Healixa Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Ian Parker

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownership0.1%
Management average tenureno data
Board average tenure4yrs

Recent management updates

Recent updates


CEO

Ian Parker

no data
Tenure

Mr. Ian Parker is Chief Executive Officer and Chairman of Healixa Inc. and serves as its Director.


Board Members

NamePositionTenureCompensationOwnership
Ian Parker
Chairman & CEOno datano data0.10%
$ 36.1k
Satyajit Deb
Member of Advisory Board4.5yrsno datano data
Michael Brubaker
Senior Advisor Sustainable Agriculture2.5yrsno datano data
Christopher Miller
Member of Advisory Board3.6yrsno datano data
Fig Annunziato
Independent Director4.5yrsno datano data
Dong Yun Kim
Independent Director4.5yrsno datano data
Christopher Galliano
Independent Director4.5yrsno datano data
Denver Riggleman
Director4.5yrsno datano data
Robert McGrath
Director & Capital Markets Advisor2.5yrsno data0.84%
$ 296.4k
Matthew A. Vogel
Directorno datano datano data
Ken Surritte
Senior Advisor Water Independence2.5yrsno datano data
Mitchell C. Shapiro
Senior Legal Advisor2.5yrsno datano data
4.0yrs
Average Tenure

Experienced Board: EMOR's board of directors are considered experienced (4 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/22 05:28
End of Day Share Price 2026/07/22 00:00
EarningsN/A
Annual EarningsN/A

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Healixa Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.